Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online February 21, 2008
Diabetes 57:1380-1386, 2008
DOI: 10.2337/db07-1528
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db07-1528v1
57/5/1380    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saberi, M.
Right arrow Articles by Donovan, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saberi, M.
Right arrow Articles by Donovan, C. M.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Locus for Hypoglycemic Detection Shifts With the Rate of Fall in Glycemia

The Role of Portal–Superior Mesenteric Vein Glucose Sensing

Maziyar Saberi1, MaryAnn Bohland1,2, and Casey M. Donovan1,2

1 Department of Kinesiology, University of Southern California, Los Angeles, California
2 Department of Biological Sciences, University of Southern California, Los Angeles, California

Corresponding author: Dr. Casey M. Donovan, University of Southern California, Departments of Kinesiology and Integrative Biology, 3560 Watt Way, PED 107, Los Angeles, CA 90089-0652. E-mail: donovan{at}usc.edu

Abbreviations: CGRP, calcitonin gene–related peptide; CNS, central nervous system

OBJECTIVE—To ascertain whether portal glucose sensing extends beyond the portal vein to the superior mesenteric vein and then test whether the role of portal–superior mesenteric glucose sensors varies with the rate of fall in glycemia.

RESEARCH DESIGN AND METHODS—Chronically cannulated rats underwent afferent ablation of the portal vein (PV) or portal and superior mesenteric veins (PMV) or sham operation (control). One week later, animals underwent hyperinsulinemic-hypoglycemic clamps in which the hypoglycemic nadir, 2.48 ± 0.06 mmol/l, was reached at a rate of decline in glucose of –0.09 or –0.21 mmol · l–1 · min–1 (PMV and control only). Additional PMV and control animals received an intravenous injection of the glucopenic agent 2-deoxyglucose.

RESULTS—Inducing hypoglycemia slowly, at a rate of –0.09 mmol · l–1 · min–1, resulted in a 26-fold increase in epinephrine (23.39 ± 0.62 nmol/l) and 12-fold increase in norepinephrine (11.42 ± 0.92 nmol/l) for controls (P < 0.001). The epinephrine response to hypoglycemia was suppressed by 91% in PMV (2.09 ± 0.07 nmol/l) vs. 61% in PV (9.05 ± 1.59 nmol/l) (P < 0.001). The norepinephrine response to hypoglycemia was suppressed by 94 and 80% in PMV and PV, respectively, compared with that in controls. In contrast, when arterial glucose was lowered to 2.49 ± 0.06 mmol/l within 20 min, no significant differences were observed in the catecholamine responses for PMV and controls over the first 45 min of hypoglycemia (20–65 min). Only at min 105 were catecholamines significantly lower for PMV vs. controls. Injection of 2-deoxyglucose induced a very rapid sympathoadrenal response with no significant differences between PMV and controls.

CONCLUSIONS—The critical locus for hypoglycemic detection shifts away from the portal-mesenteric vein to some other loci (e.g., the brain) when hypoglycemia develops rapidly.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article:

Central Versus Peripheral Glucose Sensing and the Response to Hypoglycemia
Alan D. Cherrington
Diabetes 2008 57: 1158-1159. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
DiabetesHome page
X. Fan, Y. Ding, H. Cheng, D. X. Gram, R. S. Sherwin, and R. J. McCrimmon
Amplified Hormonal Counterregulatory Responses to Hypoglycemia in Rats After Systemic Delivery of a SUR-1-Selective K+ Channel Opener?
Diabetes, December 1, 2008; 57(12): 3327 - 3334.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. D. Cherrington
Central Versus Peripheral Glucose Sensing and the Response to Hypoglycemia
Diabetes, May 1, 2008; 57(5): 1158 - 1159.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.